Analysts Estimate Allstate (ALL) to Report a Decline in Earnings: What to Look Out for
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Allstate Corporation: You Are In Good Hands
The Allstate Corp. is a strong buy due to its solid growth prospects, reliable earnings, and improved combined ratios in key business segments. Allstate's sale of its health and benefits business will unlock $3.25 billion, boosting net income and book value and enhancing financial flexibility. Allstate's profitability is evident with combined ratios under 85%, despite 2024's catastrophic losses, showcasing effective risk management and strategic business shifts.
Allstate (ALL) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes?
Allstate Closes Sale of One of Health and Benefits' Businesses
ALL exits the Employers Voluntary Benefits business and receives $2 billion from The Standard. The move aims to intensify the company's focus on the well-performing Property-Liability and Protection Services units.
Allstate (ALL) Rises But Trails Market: What Investors Should Know
The latest trading day saw Allstate (ALL) settling at $207.50, representing a +0.21% change from its previous close.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Allstate Rides on Property Liability Growth & Streamlining Initiatives
ALL benefits from rising segmental revenues, cost control and streamlining initiatives.
Two S&P 500 Giants And Biotech Play Lead Five Stocks To Watch As Market Struggles
The stock market is attempting to rebound amid President Donald Trump's trade war. The post Two S&P 500 Giants And Biotech Play Lead Five Stocks To Watch As Market Struggles appeared first on Investor's Business Daily.
Why the Market Dipped But Allstate (ALL) Gained Today
In the closing of the recent trading day, Allstate (ALL) stood at $209.28, denoting a +0.56% change from the preceding trading day.
The Allstate Corporation: A Mispriced Turnaround Insurance Stock (Short-Term Buy Rating)
The Allstate Corp. has completed a multi-year turnaround, showing strong growth and efficiency improvements, making it a mispriced stock with upside potential. The sale of Group Health and Employer Voluntary Benefits will generate $3.25 billion, potentially funding share buybacks and enhancing shareholder value. Allstate's financials are robust, with significant revenue and net income growth, a pristine balance sheet, and a forward P/E ratio lower than peer.
The Allstate Corporation (ALL) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Allstate (ALL). This makes it worthwhile to examine what the stock has in store.
Allstate Reports $73M After-Tax Catastrophe Losses in February 2025
ALL reports $1.17 billion in catastrophe losses year to date through February. In the same month, policies in force rose slightly on a sequential basis, which is likely to sustain premium growth for the insurer.
